A recent meta-analysis concluded that high sPD-L1 may predict a worse OS and PFS in lung cancer patients treated with ICIs [32], confirming the results of three previous meta-analyses [33,34,35] and in agreement with the results presented herein. The gene discussed is SPDL1; the disease is lung cancer.